Hospital
ST. Joseph Hospital LLC
ST. Joseph Hospital LLC was paid $4.67M by Medicaid between Jan 2018 and Dec 2024, across 152 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoST. JOSEPH HOSPITAL LLC
LEWISTON, ID 83501
LEWISTON, ID 83501
33aNPI1225090954assigned 04/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.67M
24GClaims211,963
24DCodes billed152
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Idaho
Rank by total paid#6 of 12
Median peer was paid$3.12M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,144 | $1.08M | |
| 2019 | 50,166 | $1.08M | |
| 2020 | 29,889 | $684K | |
| 2021 | 24,638 | $530K | |
| 2022 | 24,767 | $525K | |
| 2023 | 21,288 | $415K | |
| 2024incomplete | 15,071 | $356K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 9,645 | 8,514 | $843K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 17% | 22,828 | 16,726 | $782K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 6,318 | 5,436 | $490K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 7.2% | 6,948 | 2,513 | $337K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 4,066 | 3,466 | $307K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.8% | 1,882 | 1,743 | $225K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.4% | 3,064 | 1,279 | $207K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3.4% | 3,500 | 1,266 | $157K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.3% | 1,558 | 1,469 | $156K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 1,712 | 1,553 | $122K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.0% | 453 | 414 | $95K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 3,577 | 1,097 | $86K |
140 more codes
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.5% | 878 | $70K |
| 80053 | Comprehensive metabolic panel | 1.5% | 16,258 | $70K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.3% | 1,420 | $63K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.1% | 581 | $51K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 3,624 | $48K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 974 | $39K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,370 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,051 | $37K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 307 | $27K |
| 97162 | <1% | 630 | $21K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 431 | $21K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 371 | $20K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 665 | $20K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 176 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,793 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 257 | $18K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 141 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 959 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,264 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 728 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 61 | $14K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 83 | $14K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,680 | $13K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,712 | $12K |
| 84484 | <1% | 2,817 | $11K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 113 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,225 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,905 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 967 | $6K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 38 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 468 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,984 | $5K |
| 82803 | <1% | 1,089 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,009 | $5K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 93 | $4K |
| 96523 | <1% | 158 | $4K | |
| 83880 | <1% | 666 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,270 | $4K |
| 81001 | <1% | 4,555 | $4K | |
| 83690 | <1% | 2,307 | $4K | |
| 83735 | <1% | 2,021 | $4K | |
| G0378 | Hospital observation service, per hour | <1% | 471 | $4K |
| 83605 | <1% | 754 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,298 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,507 | $4K |
| 93017 | <1% | 53 | $3K | |
| 96415 | <1% | 18 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 108 | $3K |
| 73562 | <1% | 192 | $2K | |
| 76937 | <1% | 167 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 15 | $2K |
| 43248 | <1% | 13 | $2K | |
| 92523 | <1% | 13 | $2K | |
| 73610 | <1% | 205 | $2K | |
| 87077 | <1% | 527 | $2K | |
| 80061 | Lipid panel | <1% | 782 | $2K |
| 87186 | <1% | 493 | $2K | |
| 85610 | <1% | 2,572 | $2K | |
| 85379 | <1% | 298 | $2K | |
| 87430 | <1% | 206 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,579 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,451 | $1K |
| 83615 | <1% | 862 | $1K | |
| 84703 | <1% | 396 | $1K | |
| 73630 | <1% | 149 | $1K | |
| 87040 | <1% | 103 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,404 | $1K |
| 81003 | <1% | 2,061 | $984.71 | |
| 73130 | <1% | 115 | $982.45 | |
| 86140 | <1% | 443 | $833.83 | |
| 97597 | <1% | 73 | $815.81 | |
| 87081 | <1% | 198 | $755.53 | |
| 93971 | <1% | 15 | $735.73 | |
| 84100 | <1% | 463 | $652.83 | |
| 82977 | <1% | 308 | $651.13 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,766 | $647.11 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 108 | $616.54 |
| 73030 | <1% | 79 | $598.92 | |
| 85730 | <1% | 401 | $584.22 | |
| 84550 | <1% | 351 | $470.69 | |
| Q3014 | Telehealth originating site facility fee | <1% | 124 | $468.98 |
| 82728 | <1% | 194 | $417.20 | |
| 82248 | <1% | 217 | $397.95 | |
| 87070 | <1% | 123 | $392.75 | |
| 97166 | <1% | 15 | $375.62 | |
| 73110 | <1% | 39 | $360.13 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 352 | $350.73 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,637 | $332.96 |
| 85027 | <1% | 132 | $329.92 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,961 | $327.46 |
| 80299 | <1% | 31 | $301.05 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 297 | $256.50 |
| 84478 | <1% | 140 | $254.61 | |
| 85007 | <1% | 114 | $218.43 | |
| 87205 | <1% | 117 | $206.92 | |
| 84146 | <1% | 15 | $201.44 | |
| 82077 | <1% | 252 | $179.03 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,480 | $170.50 |
| 83550 | <1% | 136 | $167.85 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 117 | $157.97 |
| 90791 | Psychiatric diagnostic evaluation | <1% | 18 | $148.71 |
| 83540 | <1% | 138 | $148.32 | |
| 87641 | <1% | 14 | $148.01 | |
| 86900 | <1% | 38 | $142.96 | |
| 86901 | <1% | 38 | $138.42 | |
| 72040 | <1% | 12 | $138.09 | |
| J3490 | Unclassified drugs | <1% | 572 | $135.76 |
| 94760 | <1% | 1,565 | $130.58 | |
| 96127 | <1% | 27 | $107.60 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30 | $104.36 |
| 90686 | <1% | 48 | $94.71 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 123 | $90.56 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 487 | $82.45 |
| 82962 | <1% | 107 | $79.65 | |
| 72100 | <1% | 16 | $77.84 | |
| G0008 | Administration of influenza virus vaccine | <1% | 49 | $64.43 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 181 | $54.15 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 56 | $44.10 |
| 82607 | <1% | 17 | $32.32 | |
| 84439 | <1% | 14 | $21.38 | |
| 85652 | <1% | 16 | $18.00 | |
| 82565 | <1% | 14 | $13.79 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 928 | $11.25 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 119 | $6.74 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 44 | $5.90 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 12 | $5.82 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 12 | $5.52 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 125 | $5.49 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 42 | $4.74 |
| 99152 | 0% | 13 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 13 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 51 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 64 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 18 | $0.00 |
| 96376 | 0% | 581 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 148 | $0.00 |
| C1769 | Guide wire | 0% | 382 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 481 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 163 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRAYLOR, JOHNETTA (DIR LICENSE AND CERTIFICATION)
| Provider | Location | Paid |
|---|---|---|
| Logan General Hospital LLC | Logan, WV | $43.43M |
| Phc-Cleveland LLC | Cleveland, MS | $23.43M |
| Hartsville, LLC | Hartsville, SC | $18.42M |
| Logan Memorial Hospital LLC | Russellville, KY | $14.29M |
| Southwestern Medical Center, LLC | Lawton, OK | $9.40M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $6.80M |
| Watertown Medical Center LLC | Watertown, WI | $6.31M |
| Amg - Livingston, LLC | Livingston, TN | $5.52M |
| Logan General Hospital LLC | Logan, WV | $4.91M |
| Riverton Memorial Hospital LLC | Riverton, WY | $4.65M |
| Livingston Regional Hospital LLC | Livingston, TN | $4.33M |
| Hartsville Medical Group LLC | Hartsville, SC | $4.16M |
| Mexia Principal Healthcare Limited Partnership | Mexia, TX | $2.19M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $1.27M |
| Texas Specialty Physicians | Palestine, TX | $1.26M |
| ST Joseph Hospital LLC | Lewiston, ID | $1.10M |
| Watertown Physician Practices LLC | Watertown, WI | $244K |
| Watertown Physician Practices LLC | Watertown, WI | $175K |
| Amg-Livingston LLC | Livingston, TN | $165K |
| Watertown Physician Practices LLC | Watertown, WI | $149K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.